Latest News about Joseph Tucker
Recent news which mentions Joseph Tucker
Enveric Biosciences Advances Non-Hallucinogenic DMT Analog Drug With Promising Preclinical Results
November 25, 2024
From Benzinga
Enveric Biosciences Trims Losses, Eyes Key Drug Approval For Difficult-To-Treat Mental Health Disorders
November 18, 2024
From Benzinga
Enveric Biosciences Out-Licenses Key Program To MycoMedica In $62M Deal
November 12, 2024
From Benzinga
From Benzinga
Psychedelics 2.0: Companies Explore Safer, More Targeted Therapies
October 04, 2024
From Benzinga
Non-Hallucinogenic Psychedelic Treatment For Anxiety And Depression In Pre-Clinical Models: Enveric Biosciences' Breakthrough Research
September 25, 2024
From Benzinga
Non-Hallucinogenic Psychedelic Treatment For Mental Health Disorders Shows Potential To Be Dosed Orally
July 25, 2024
From Benzinga
From Benzinga
From Benzinga
Cannabinoids With Chemotherapy For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For Patented Methods
May 08, 2024
From Benzinga
Enveric Completes Manufacturing Of Its Psilocin Prodrug To Supply Drug Material For Completion Of Preclinical Program
August 21, 2023
Tickers
ENVB
From Benzinga
Enveric Unveils Positive Results From Preclinical Studies Supporting Metabolic Profile Of Its Psilocin Prodrug For Anxiety
July 24, 2023
Tickers
ENVB
From Benzinga
Enveric Unveils Positive Results From Animal Studies Of Its Psilocin Prodrug For Anxiety
July 17, 2023
Tickers
ENVB
From Benzinga
Psychedelics Company Takes 'A Key Step' With New Formulation Of Its Psilocin Prodrug For Anxiety
June 26, 2023
Tickers
ENVB
From Benzinga
Enveric Stock Trading Higher On Notice Of Allowance For Patent Application For Its Carboxylated Psilocybin Derivatives
June 05, 2023
Tickers
ENVB
From Benzinga
Enveric Stock Soars On Reception Of Notice Of Allowance For Patent Application For Its Psilocin Prodrug Designs
May 24, 2023
Tickers
ENVB
From Benzinga
Enveric Biosciences Receives Notice Of Allowance From US Patent And Trademark Office For Novel Prodrug Of Psilocin
May 18, 2023
Tickers
ENVB
From Benzinga
EXCLUSIVE: Reinventing Mental Health & Next-Gen Psychedelics, 'Access And Clinical Data Are Key'
April 14, 2023
From Benzinga
Enveric Biosciences Files Provisional Patent For CBD+Celecoxib Conjugate For Osteoarthritis
February 08, 2022
From Benzinga
Cannabis Movers & Shakers: NORML, TGOD, Enveric Biosciences, Dalwhinnie Enterprises
December 10, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.